Birchview Capital as of Dec. 31, 2023
Portfolio Holdings for Birchview Capital
Birchview Capital holds 58 positions in its portfolio as reported in the December 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Bristol Myers Squibb (BMY) | 28.2 | $36M | 702k | 51.31 | |
| Neurocrine Biosciences (NBIX) | 8.0 | $10M | 77k | 131.76 | |
| Biodesix (BDSX) | 7.5 | $9.6M | 5.2M | 1.84 | |
| ACADIA Pharmaceuticals (ACAD) | 5.9 | $7.5M | 240k | 31.31 | |
| Prothena Corp SHS (PRTA) | 4.8 | $6.2M | 170k | 36.34 | |
| ImmunoGen | 4.4 | $5.6M | 188k | 29.65 | |
| Quidel Corporation | 3.8 | $4.8M | 65k | 73.70 | |
| Encana Corporation (OVV) | 2.9 | $3.7M | 84k | 43.92 | |
| Aziyo Biologics (ELUT) | 2.8 | $3.6M | 1.7M | 2.16 | |
| Phreesia (PHR) | 2.1 | $2.7M | 115k | 23.15 | |
| United Therapeutics Corporation (UTHR) | 1.9 | $2.4M | 11k | 219.89 | |
| Cytokinetics (CYTK) | 1.6 | $2.1M | 25k | 83.49 | |
| Foghorn Therapeutics (FHTX) | 1.6 | $2.1M | 321k | 6.45 | |
| Silk Road Medical Inc Common | 1.5 | $1.9M | 158k | 12.27 | |
| Inhibrx | 1.4 | $1.8M | 48k | 38.00 | |
| Masimo Corporation (MASI) | 1.4 | $1.8M | 15k | 117.21 | |
| Harrow Health (HROW) | 1.3 | $1.7M | 150k | 11.20 | |
| 10x Genomics Cl A Com (TXG) | 1.3 | $1.7M | 30k | 55.96 | |
| Corcept Therapeutics Incorporated (CORT) | 1.3 | $1.6M | 50k | 32.48 | |
| Alkermes SHS (ALKS) | 1.1 | $1.4M | 50k | 27.74 | |
| Equitrans Midstream Corp (ETRN) | 1.1 | $1.4M | 133k | 10.18 | |
| Alphatec Holdings (ATEC) | 1.0 | $1.3M | 88k | 15.11 | |
| Axogen (AXGN) | 0.9 | $1.2M | 173k | 6.83 | |
| Stoke Therapeutics (STOK) | 0.9 | $1.1M | 210k | 5.26 | |
| Protagonist Therapeutics (PTGX) | 0.9 | $1.1M | 48k | 22.93 | |
| Travere Therapeutics (TVTX) | 0.9 | $1.1M | 122k | 8.99 | |
| Apellis Pharmaceuticals (APLS) | 0.8 | $1.1M | 18k | 59.86 | |
| Accelr8 Technology | 0.7 | $883k | 225k | 3.92 | |
| Pioneer Natural Resources | 0.7 | $855k | 3.8k | 224.88 | |
| Docgo (DCGO) | 0.7 | $839k | 150k | 5.59 | |
| Progyny (PGNY) | 0.6 | $818k | 22k | 37.18 | |
| Arvinas Ord (ARVN) | 0.5 | $617k | 15k | 41.16 | |
| Kiniksa Pharmaceuticals | 0.4 | $526k | 30k | 17.54 | |
| Kalvista Pharmaceuticals (KALV) | 0.4 | $490k | 40k | 12.25 | |
| Xenon Pharmaceuticals (XENE) | 0.4 | $461k | 10k | 46.06 | |
| Bluebird Bio | 0.3 | $443k | 321k | 1.38 | |
| Karyopharm Therapeutics | 0.3 | $406k | 470k | 0.86 | |
| Amicus Therapeutics (FOLD) | 0.3 | $397k | 28k | 14.19 | |
| Halozyme Therapeutics (HALO) | 0.3 | $370k | 10k | 36.96 | |
| Coherus Biosciences (CHRS) | 0.3 | $366k | 110k | 3.33 | |
| Springworks Therapeutics (SWTX) | 0.3 | $365k | 10k | 36.50 | |
| Biohaven Pharmaceutical Holding | 0.2 | $315k | 7.4k | 42.80 | |
| Keros Therapeutics (KROS) | 0.2 | $278k | 7.0k | 39.76 | |
| Xencor (XNCR) | 0.2 | $261k | 12k | 21.23 | |
| Cullinan Oncology (CGEM) | 0.2 | $256k | 25k | 10.19 | |
| G1 Therapeutics | 0.2 | $244k | 80k | 3.05 | |
| Zentalis Pharmaceuticals (ZNTL) | 0.2 | $242k | 16k | 15.15 | |
| Sarepta Therapeutics (SRPT) | 0.2 | $241k | 2.5k | 96.43 | |
| Liquidia Technologies (LQDA) | 0.2 | $241k | 20k | 12.03 | |
| Cabaletta Bio (CABA) | 0.2 | $227k | 10k | 22.70 | |
| Castle Biosciences (CSTL) | 0.2 | $216k | 10k | 21.58 | |
| Wave Life Sciences SHS (WVE) | 0.2 | $202k | 40k | 5.05 | |
| Gossamer Bio (GOSS) | 0.1 | $126k | 138k | 0.91 | |
| BioCryst Pharmaceuticals (BCRX) | 0.1 | $120k | 20k | 5.99 | |
| 2seventy Bio | 0.1 | $85k | 20k | 4.27 | |
| Inflarx Nv (IFRX) | 0.1 | $82k | 50k | 1.63 | |
| Ventyx Biosciences (VTYX) | 0.1 | $71k | 29k | 2.47 | |
| Yield10 Bioscience | 0.0 | $4.5k | 19k | 0.24 |
